You just read:

Viking Therapeutics Announces Results of Gene Expression Analysis from In Vivo Study of VK2809 in Non-Alcoholic Steatohepatitis (NASH)

News provided by

Viking Therapeutics, Inc.

Sep 11, 2017, 07:05 ET